{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:43:49Z","timestamp":1761486229012,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Oligometastatic disease in lung cancer is not a rare condition as previously thought. Among 812 non-small cell lung cancer patients treated surgically with lung resection between October 2011 and October 2018 at the Department of Thoracic Surgery, Florence Nightingale Hospitals, Turkey, 28 patients (3.4%) had synchronous cranial metastases. We analyzed synchronous isolated cranial metastases patients treated by locally ablative treatments (surgery, radiotherapy, or both). Metastases existing at the diagnosis of primary cancer were considered as synchronous, and their treatment was performed before (at least 1 month) or after (for maximum 1 month) surgery of the primary lung lesion. Prognostic factors affecting survival are evaluated retrospectively to identify clinical factors predicting survival in an effort to better select patients for surgery. Patients having T1-T2 primary lung tumors, no mediastinal lymph node metastasis, receiving minor anatomical lung resection, receiving neoadjuvant chemotherapy, having single cranial metastasis, and receiving surgical cranial metastasectomy were found to have better survival. According to tumor histology, having adenocarcinoma, and not having lymphovascular or visceral pleura invasion correlated with better survival. Average survival time was 52.1 months and median survival was 32 months. The last mortality during the follow-up was at 24 months; cumulative survival was 48.3% at that time. Our study was designed to define the criteria for patients with oligometastatic disease who may benefit from lung resection.<\/jats:p>","DOI":"10.3389\/fsurg.2021.645870","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T09:09:44Z","timestamp":1614244184000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["In Spite of Curative Radical Pulmonary Procedures, Lesser Pulmonary Resection Shows More Favorable Prognosis in Surgically Treated NSCLC With Synchronous Isolated Cranial Oligometastases"],"prefix":"10.3389","volume":"8","author":[{"given":"Erkan","family":"Kaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ey\u00fcp Halit","family":"Yard\u0131mc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahnavi","family":"Kakuturu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Toker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/thoraxjnl-2012-202297","article-title":"Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden, and the UK: a population-based study, 2004\u20132007","volume":"68","author":"Walters","year":"2013","journal-title":"Thorax"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1634\/theoncologist.2010-0322","article-title":"Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens","volume":"15","author":"Grossi","year":"2010","journal-title":"Oncologist"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","article-title":"PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer","volume":"31","author":"Paz-Ares","year":"2013","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1470-2045(11)70232-7","article-title":"Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis","volume":"12","author":"Shaw","year":"2011","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.lungcan.2010.05.003","article-title":"Surgical treatment of oligometastatic non-small cell lung cancer","volume":"69","author":"Pfannschmidt","year":"2010","journal-title":"Lung Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.lungcan.2012.09.011","article-title":"Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage","volume":"78","author":"Collaud","year":"2012","journal-title":"Lung Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.jtho.2017.08.008","article-title":"The role of thoracic surgery in the therapeutic management of metastatic non-small cell lung cancer","volume":"12","author":"David","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.athoracsur.2017.10.040","article-title":"Operation and chemotherapy: Prognostic factors for lung cancer with one synchronous metastasis","volume":"105","author":"Toffart","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","article-title":"Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (NCT01282450)","volume":"10","author":"De Ruysscher","year":"2012","journal-title":"J Thorac Oncol"},{"key":"B14","doi-asserted-by":"crossref","unstructured":"Non-Small Cell Lung Cancer (Version 2.2021)2021","DOI":"10.1016\/S0169-5002(21)00202-6"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.athoracsur.2018.10.029","article-title":"Synchronous oligometastatic lung cancer deserves a dedicated management","volume":"107","author":"Loi","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1067\/mtc.2001.116201","article-title":"Surgical treatment of primary lung cancer with synchronous brain metastases","volume":"122","author":"Billing","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.lungcan.2015.02.013","article-title":"Prognostic factors for cases with no extracranial metastasis in whom brain metastasis is detected after resection of non-small cell lung cancer","volume":"88","author":"Bae","year":"2015","journal-title":"Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1055\/s-0033-1360477","article-title":"The outcome of bifocal surgical resection in non-small cell lung cancer with synchronous brain metastases: results of a single center retrospective study","volume":"62","author":"Yuksel","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/ejcts\/ezaa005","article-title":"Lung cancer surgery in oligometastatic patients: outcome and survival","volume":"57","author":"Casiraghi","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.athoracsur.2014.01.052","article-title":"A prospective study of surgical procedures for patients with oligometastatic non-small cell lung cancer","volume":"98","author":"Endo","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/ejcts\/ezz384","article-title":"Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis","volume":"57","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"CD009519","DOI":"10.1002\/14651858.CD009519.pub2","article-title":"PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer","volume":"2014","author":"Schmidt-Hansen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3171\/jns.1995.83.4.0605","article-title":"Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991","volume":"83","author":"Wronski","year":"1995","journal-title":"J Neurosurg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lungcan.2013.07.023","article-title":"Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors","volume":"82","author":"Griffioen","year":"2013","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/ejcts\/ezr042","article-title":"Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?","volume":"41","author":"Mordant","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1378\/chest.119.5.1469","article-title":"Surgical management of non-small cell lung cancer with synchronous brain metastases","volume":"119","author":"Bonnette","year":"2001","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.athoracsur.2006.01.021","article-title":"Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping","volume":"81","author":"Riquet","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","article-title":"Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer","volume":"29","author":"Krebs","year":"2011","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e50141","DOI":"10.1371\/journal.pone.0050141","article-title":"Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs","volume":"7","author":"Lussier","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.645870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T23:20:52Z","timestamp":1671405652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.645870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":29,"alternative-id":["10.3389\/fsurg.2021.645870"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2021.645870","relation":{},"ISSN":["2296-875X"],"issn-type":[{"type":"electronic","value":"2296-875X"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"article-number":"645870"}}